oxazolidin-2-one has been researched along with Neointima in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barter, PJ; Johns, D; Li, Y; Ong, KL; Rye, KA; Sun, Y; Wu, BJ | 1 |
| Barter, PJ; Hou, L; Johns, D; Li, Y; Ong, KL; Rye, KA; Shrestha, S; Sun, Y; Wu, BJ | 1 |
| Barter, PJ; Hou, L; Johns, D; Ong, KL; Rye, KA; Shrestha, S; Wu, BJ | 1 |
3 other study(ies) available for oxazolidin-2-one and Neointima
| Article | Year |
|---|---|
The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits.
Topics: Animals; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Hyperplasia; Intercellular Adhesion Molecule-1; Male; Neointima; Oxazolidinones; Rabbits; Vascular Cell Adhesion Molecule-1 | 2019 |
Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
Topics: Angioplasty, Balloon; Animals; Anticholesteremic Agents; Apolipoprotein A-I; Carrier Proteins; Cell Proliferation; Cells, Cultured; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Disease Models, Animal; Humans; Hyperplasia; Iliac Artery; Membrane Proteins; Metals; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Oxazolidinones; Phosphatidylinositol 3-Kinase; Prosthesis Design; Proto-Oncogene Proteins c-akt; Rabbits; Scavenger Receptors, Class B; Signal Transduction; Stents; Time Factors; Vascular System Injuries | 2017 |
Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit.
Topics: Animals; Anticholesteremic Agents; Aorta, Abdominal; Apolipoprotein A-I; Carrier Proteins; Cell Movement; Cell Proliferation; Cells, Cultured; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hyperplasia; Male; Membrane Proteins; Neointima; Oxazolidinones; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rabbits; Regeneration; RNA Interference; Scavenger Receptors, Class B; Signal Transduction; Time Factors; Transfection; Up-Regulation; Vascular System Injuries; Vasodilation; Vasodilator Agents | 2015 |